Discovery of a bifunctional PKMYT1-targeting PROTAC empowered by AI-generation
D16-M1P2, a novel bifunctional PROTAC targeting PKMYT1, was developed using an AI-driven generative platform. It exhibits dual mechanisms of action, effectively degrading and inhibiting PKMYT1, leading to significant antitumor responses in xenograft models. The compound shows high selectivity and favorable pharmacokinetic properties, indicating its potential as a therapeutic agent for cancers with specific genetic alterations. This research underscores the promise of AI in drug discovery and the development of targeted cancer therapies.
Methanol biotransformation for the production of biodegradable plastic monomer L-lactate in yeast
研究表明，通过工程化酵母菌Ogataea polymorpha，可以从甲醇中高效生产可生物降解的塑料单体L-乳酸。该技术结合了液态阳光技术和甲醇生物转化，展示了碳负生产的潜力。技术经济分析和生命周期评估表明，该生产过程在商业上具有可行性，并能显著降低温室气体排放，推动可持续塑料生产。
The expression, regulation, and function of human endogenous retroviruses in genitourinary cancers
The review discusses the expression, regulation, and function of human endogenous retroviruses (HERVs) in genitourinary cancers, highlighting their role in oncogenesis and potential as biomarkers and therapeutic targets. It emphasizes the need for further research to validate HERVs in clinical applications, including immunotherapy and early detection strategies.
Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing
本研究探讨了TBK1和IKKε在肿瘤细胞对免疫细胞攻击中的作用，发现抑制这两种激酶可以增强肿瘤对CD8 T细胞和自然杀伤细胞的敏感性。研究表明，RIPK1的磷酸化状态是调节肿瘤细胞生存与死亡的重要因素，揭示了新的治疗靶点，可能为癌症免疫治疗提供新的策略。
Disruption of the PIKfyve complex unveils an adaptive mechanism to promote lysosomal repair and mitochondrial homeostasis
该研究探讨了PIKfyve复合体在细胞应激下的适应机制，揭示其在溶酶体修复和线粒体功能中的关键作用。研究表明，PIKfyve抑制剂在神经退行性疾病模型中具有潜在的治疗应用，可能通过增强溶酶体膜的完整性和线粒体的代谢能力来发挥作用。这一发现为针对神经退行性疾病的治疗策略提供了新的思路。
Isoallolithocholic acid ameliorates intestinal inflammation via metabolically reprogrammed macrophages
IsoalloLCA, a bile acid metabolite, has been shown to alleviate intestinal inflammation in pediatric patients with inflammatory bowel disease (IBD). The study demonstrates that isoalloLCA reduces TNF production and enhances the expression of anti-inflammatory regulatory T cells in both human and murine models. By metabolically reprogramming macrophages, isoalloLCA enhances oxidative phosphorylation, thereby amplifying its anti-inflammatory effects. This research highlights the potential of isoalloLCA as a promising therapeutic avenue for treating IBD, addressing a significant global health concern.
Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy
Sibiriline is a newly identified dual inhibitor of necroptosis and ferroptosis, showing significant potential in treating complex diseases like Parkinson's and cystic fibrosis. The study reveals its mechanisms of action, including inhibition of RIPK1 kinase activity and lipid peroxidation, positioning it as a promising candidate for innovative therapies. Its favorable safety profile and efficacy in preclinical models suggest strong investment potential in the biotechnology sector.
Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1
研究发现，CTSL作为双重靶点，能够在增强抗PD-L1治疗的抗肿瘤效果的同时，减轻因治疗引起的肌肉消耗。该研究通过小鼠模型和临床数据分析，揭示了CTSL在癌症相关肌肉消耗中的关键作用，表明其在未来癌症治疗中的潜在应用价值。
TRIM63/IRF-8 axis promotes tumor progression and immunosuppression of melanoma with BRAF mutation
研究表明，E3泛素连接酶TRIM63在BRAF突变黑色素瘤中通过促进IRF-8的降解，增强肿瘤进展和免疫抑制。TRIM63的高表达与患者预后不良相关，揭示了其作为潜在治疗靶点的价值。该研究为理解黑色素瘤的分子机制提供了新视角，可能推动相关治疗策略的发展。
ACBP/DBI neutralization for the prevention and treatment of malignant and non-malignant liver diseases
ACBP/DBI中和显示出对多种肝脏疾病的预防和治疗潜力，尤其是肝细胞癌（HCC）。研究表明，ACBP/DBI在HCC患者中升高，与疾病严重程度相关。通过小鼠模型的实验，ACBP/DBI中和能够有效减轻肝脏损伤，具有显著的商业价值和投资潜力。
TRIM25 degrades BRD7 protein stability through the ubiquitin proteasome pathway to promote breast cancer progression and paclitaxel resistance by activating YB1/Bcl-2 transcription axis
TRIM25作为一种E3泛素连接酶，通过降解BRD7蛋白，促进乳腺癌细胞的增殖和紫杉醇耐药性。研究表明，TRIM25在乳腺癌组织中高表达，并与患者的预后密切相关。TRIM25的高表达与乳腺癌的临床阶段及不良预后相关，提示其可能作为潜在的治疗靶点。
NEK7 couples SDHB to orchestrate respiratory chain electron transport homeostasis that impedes liver fibrosis
研究发现NEK7在肝细胞线粒体中发挥关键作用，通过结合SDHB维持线粒体复合体II的稳定性，从而调节电子传输的稳态。NEK7缺失会导致肝纤维化加重，而其过表达则能显著改善肝纤维化。这一发现为肝纤维化的治疗提供了新的潜在靶点，具有重要的临床应用前景。
USP13 dictates Ran turnover and vulnerability to ferroptosis in diffuse large B cell lymphoma (DLBCL)
本研究揭示了去泛素化酶USP13在弥漫性大B细胞淋巴瘤（DLBCL）中的关键作用，USP13通过调节Ran的稳定性影响肿瘤进展。研究表明，USP13的抑制剂Spautin-1能够诱导细胞铁死亡，并与传统化疗药物多柔比星和环磷酰胺联用，显示出良好的协同效果，为DLBCL的治疗提供了新的思路和临床试验的基础。
Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5
SVEP1 is identified as a crucial biomarker in intrahepatic cholangiocarcinoma (ICC), with its downregulation linked to poor clinical outcomes. The study demonstrates that decreased SVEP1 expression enhances tumor cell proliferation, migration, and invasion through the activation of the Jag2/Notch1/Hes5 signaling pathway. This research underscores the potential of SVEP1 as a therapeutic target and prognostic factor in ICC, providing insights into the mechanisms driving tumor progression and metastasis.
Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myeloma
本研究探讨了RNA聚合酶I抑制剂CX-5461和BMH-21在多发性骨髓瘤中的应用，发现这两种抑制剂通过调节NK细胞激活配体的表达，增强了NK细胞的抗肿瘤活性。BMH-21表现出更强的免疫刺激效果，而CX-5461则通过诱导DNA损伤抑制NK细胞功能。研究结果为多发性骨髓瘤的免疫治疗提供了新的思路，强调了RNA聚合酶I作为治疗靶点的潜力。